TegoScience Inc.

₩6,410As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:191420Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (11.69%)
Div yield —
ROE (25.29%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.60
PE TTM —
TSR TTM (63.89%)
Mkt cap ₩51.32B
ROIC (36.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩7,264
13.32%
53.06%
Hold 0|5|2|11|12
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
89.36
90.39
87.31
94.79
(9.10%)
(8.22%)
(9.17%)
3.12%
Revenue₩B
6.247
6.552
6.659
7.052
2.20%
8.54%
9.34%
11.83%
Peers (US$37.84M)
Cap (US$)
PE
38.76M
50.39x
37.44M
—
33.07M
7.715x
37.87M
—
Capital
TTM
5Y
10Y
Leveragex
5.519
0.171
0.127
EBIT/Intx
3.458
3.185
2.085
Own earn%
(41.37)
(17.13)
(17.39)
Sh yield%
8.62
30.46
30.52
Owners
Insiders/Inst%
5.62
63.04
Short interest%
3.82
SBC / revenue%
2.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
23–34
$1 testx
—
Incr. ROIC%
3